You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

targeted therapy

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenocarcinoma of the Stomach Trial in Goyang (Anti-EGFR antibody in combination with weekly paclitaxel)

Recruiting
  • Adenocarcinoma of the Stomach
  • Anti-EGFR antibody in combination with weekly paclitaxel
  • Goyang, Gyeonggi, Korea, Republic of
    National Cancer Center
Nov 29, 2022

Breast Cancer, Adjuvant Therapy Trial in Fuzhou (Pyrotinib+Trastuzumab+Capecitabine, Trastuzumab+Pertuzumab/Trastuzumab)

Recruiting
  • Breast Cancer
  • Adjuvant Therapy
  • Fuzhou, Fujian, China
    Fujian Medical University Union Hospital
Mar 14, 2022

Community-Acquired Pneumonia, Antimicrobial Stewardship, Point-of-Care Testing Trial in United States (Rapid Diagnostic Testing,

Recruiting
  • Community-Acquired Pneumonia
  • +2 more
  • Rapid Diagnostic Testing
  • Pharmacist-led de-escalation
  • Weston, Florida
  • +10 more
Jan 5, 2023

Breast Cancer Trial in Birmingham ([89Zr]-Df-Trastuzumab, PET/MRI Imaging)

Recruiting
  • Breast Cancer
  • Birmingham, Alabama
    The Kirklin Clinic
Feb 1, 2022

Colon Adenocarcinoma, Microsatellite Stable Colon Carcinoma, Stage IIB Colon Cancer AJCC v8 Trial (drug, biological, procedure,

Not yet recruiting
  • Colon Adenocarcinoma
  • +4 more
  • (no location specified)
Jan 24, 2023

Metastatic Colon Cancer Trial in Italy, Romania, Spain (AI)

Not yet recruiting
  • Metastatic Colon Cancer
  • AI
  • Firenze, Italy
  • +5 more
May 30, 2022

Chronic Myelogenous Leukemia Trial in Tampa (Therapy for Targeted Therapy-related Fatigue (TTF), Wait-List Control Condition

Completed
Has Results
  • Chronic Myelogenous Leukemia
  • Therapy for Targeted Therapy-related Fatigue (TTF)
  • Wait-List Control Condition (WLC)
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 15, 2021

Cancer, Solid Tumor, Adult Trial in France (research of druggable molecular alterations on tumor biopsy)

Active, not recruiting
  • Cancer
  • Solid Tumor, Adult
  • research of druggable molecular alterations on tumor biopsy
  • Bordeaux, France
  • +3 more
May 16, 2022

HRD Score in Chinese Ovarian Cancer Patients Benefiting From

Recruiting
  • Ovarian Cancer
    • Shanghai, Shanghai, China
      The Obstetrics and Gynecology Hospital of Fudan University
    Feb 24, 2022

    Epithelial Ovarian, Fallopian Tube, Primary Peritoneal Cancer Trial in Houston (Paclitaxel/Bev (control), Paclitaxel/Bev + ZA

    Recruiting
    • Epithelial Ovarian
    • +2 more
    • Paclitaxel/Bev (control)
    • Paclitaxel/Bev + ZA (experimental)
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 9, 2022

    Crohn's Disease Trial in Chicago (Vedolizumab, Adalimumab, Ustekinumab)

    Not yet recruiting
    • Crohn's Disease
    • Chicago, Illinois
      University of Chicago Medicine
    Sep 13, 2023

    Node-positive Breast Cancer Trial (Targeted axillary lymph node dissection)

    Not yet recruiting
    • Node-positive Breast Cancer
    • Targeted axillary lymph node dissection
    • (no location specified)
    Jan 6, 2023

    HRQOL in Locally Advanced Thyroid Carcinoma

    Recruiting
    • Thyroid Cancer
    • +2 more
    • Tyrosine kinase inhibitor drugs.
    • Fuzhou, Fujian, China
      Road Fuma No.420
    Apr 11, 2023

    Molecular Analysis and Treatment Options of SCLC

    Recruiting
    • Small-cell Lung Cancer
    • +4 more
    • Shanghai, China
      Shanghai Chest Hospital
    Jul 6, 2023

    Colorectal Tumors, Tumor Metastasis, Liver Tumors Trial in Shanghai (chemo ± targeted therapy)

    Completed
    • Colorectal Neoplasms
    • +3 more
    • chemotherapy ± targeted therapy
    • Shanghai, Shanghai, China
      Zhongshan hospital, Fudan university
    Jun 12, 2022

    HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

    Recruiting
    • HR+/HER2- Advanced Breast Cancer
    • Targeted Therapy
    • Beijing, Beijing, China
      National Cancer Center/National Clinical Research Center for Can
    Aug 1, 2023

    HER-2 Positive Breast Cancer Patients at High Altitude

    Not yet recruiting
    • HER2-positive Breast Cancer
    • +3 more
    • High altitude
    • Xining, Qinghai, China
      Affiliated Hospital of Qinghai University
    Sep 30, 2021

    Colorectal Cancer Trial in Chongqing (CIK combined with chemo group, CIK combined immunotherapy group, CIK combined targeted

    Recruiting
    • Colorectal Cancer
    • CIK combined with chemotherapy group
    • +3 more
    • Chongqing, Chongqing, China
      Southwest Hospital, Army Medical University (Third Military Medi
    Jan 6, 2023

    Breast Cancer Female Trial in Tomsk ([99mTc]Tc-G3-(G3S)3C)

    Enrolling by invitation
    • Breast Cancer Female
    • Tomsk, Russian Federation
      Olga
    Jun 19, 2023

    Advanced Cancer, Metastatic Cancer Trial in Shanghai (biological, device, drug)

    Recruiting
    • Advanced Cancer
    • Metastatic Cancer
    • Autologous Adoptive immune cells
    • +2 more
    • Shanghai, Shanghai, China
      Fudan University Pudong Medical Center
    Jun 24, 2022

    Gliosarcoma, Recurrent Glioblastoma Trial in Chicago (Laboratory Biomarker Analysis, Pharmacological Study, Targeted Molecular

    Completed
    Has Results
    • Gliosarcoma
    • Recurrent Glioblastoma
    • Laboratory Biomarker Analysis
    • +2 more
    • Chicago, Illinois
      Northwestern University
    Aug 5, 2022

    NSCLC, EGF-R Positive NSCLC Trial in Wuxi (Parimparib, Chemotherapy drug, Targeted Therapy Agent)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • EGF-R Positive Non-Small Cell Lung Cancer
    • Wuxi, Jiangsu, China
      Affiliated Hospital of Jiangnan University
    Jan 30, 2023

    Resectable Non-Small Cell Lung Cancer Stages IIB-IIIB

    Recruiting
    • Non Small Cell Lung Cancer
    • anti-PD-1 or anti-PD-L1
    • +2 more
    • Shanghai, China
      Oncology Department, Shanghai Chest Hospital
    Jul 26, 2022

    Locally Advanced Unresectable Pancreatic Adenocarcinoma Trial (Padeliporfin Vascular Targeted Photodynamic (VTP) therapy)

    Not yet recruiting
    • Locally Advanced Unresectable Pancreatic Adenocarcinoma
    • Padeliporfin Vascular Targeted Photodynamic (VTP) therapy
    • (no location specified)
    Jun 25, 2023

    Unresectable Metastatic Colorectal Cancer Trial (Bifico combined with chemo plus targeted therapy, chemo plus targeted therapy)

    Not yet recruiting
    • Unresectable Metastatic Colorectal Cancer
    • Bifico combined with chemotherapy plus targeted therapy
    • chemotherapy plus targeted therapy
    • (no location specified)
    Jul 13, 2021